Skip to main content
Biocat
Català
English
Español
Moebio
B·Debate
Press room
Report of Activities
Contact
Search form
Search
Toggle navigation
What we do
Acceleration and Innovation
Open Innovation Forum
The Investment Readiness Series
Health & Bio Team Dating
Healthcare Investment Forum
Fairs and Congresses
Training and talent
d·HEALTH Barcelona Part Time
d·HEALTH Barcelona
SHORT PROGRAMS
Pitch Training Program
CRAASH Barcelona
European networks and projects
BRIGHT
INNAXE
EDAH
BioMan4R2
boost4health
European Council of Bioregions (CEBR)
BILAT USA 2.0
Bio-CT
BioNanoMed
EDCA
ETTBio
HealthTIES
Interbio
Oncocat
ELIXIR
Safe-N-Medtech
Onconet
Transbio SUDOE
Debates and dialogues
Presentation of the 2022 BioRegion Report
Pandemics: Overcoming COVID-19 and preparing for the future
B·Debate - International Center for Scientific Debate Barcelona
BioRegion Forum
Strategic projects
EIT Health
RIS3CAT Community
Job offers
About the BioRegion
What is the BioRegion?
Invest in Catalonia
Key figures on the BioRegion
Clinical trials in the BioRegion
The BioRegion of Catalonia: Key bibliometric facts
Biocat publications
BioRegion Directory
Access to technological market
News & Stories
Events
News
Blog
Start-up Generation
Press room
Press contact
Press releases
Press Clipping
Gallery and video
Resource Centre COVID-19
Who we are
About Biocat
Vision, mission and values
Corporate structure
Board of Trustees
Team
Corporate identity
Contractor profile
You are here
Home
>
Current news
>
News
>
empreses
empreses
HIGHLIGHTS: News in CAR-T, Orikine round, Roche investment in Catalonia, first genetic variant for multiple sclerosis
27.07.2023
